您的位置: 首页 > 农业专利 > 详情页

TETRAHYDROOXEPINOPYRIDINE COMPOUND
专利权人:
ASTELLAS PHARMA INC.
发明人:
KOGANEMARU, Yohei,MIYAMOTO, Satoshi,NAGASHIMA, Shinya,KAMIKAWA, Akio,YONEZAWA, Koichi,KOIZUMI, Yuka,AOKI, Satoshi,OGIYAMA, Takashi,KAWAKAMI, Shimpei,KUNIKAWA, Shigeki,SATO, Ryo,SHISHIKURA, Junichi,KAK
申请号:
SG11201801193Q
公开号:
SG11201801193QA
申请日:
2016.08.18
申请国别(地区):
SG
年份:
2018
代理人:
摘要:
[Problem] To provide a compound which has a positive allosteric modulating effect (PAM effect) for an ±7 nicotinic acetylcholine receptor (±7 nACh receptor). [Solution] The inventors have achieved the present invention by making studies on PAM effects for an ±7 nACh receptor and confirming that a tetrahydrooxepinopyridine compound has a PAM effect for an ±7 nACh receptor. A tetrahydrooxepinopyridine compound according to the present invention has a PAM effect for an ±7 nACh receptor, and is promising as a prophylactic or therapeutic agent for dementia, cognitive impairment, schizophrenia, Alzheimer's disease, CIAS, negative symptoms of schizophrenia, inflammatory diseases or pain.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充